Displaying 1 - 9 of 9
Immune-Mediated and Cholestatic Diseases

Should we focus on managing QoL?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Debate the issues

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Event summary

Webcasts
View
Immune-Mediated and Cholestatic Diseases

How do we holistically treat patients with PBC?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Should we focus on monitoring ALP?

Webcasts
View
Metabolism, Alcohol & Toxicity

Session 1: Identifying Patients with NASH and Significant Fibrosis: Are we doing enough?

Webcasts
View
Metabolism, Alcohol & Toxicity

Session 2: Managing patients with NASH and Significant Fibrosis – Now and in the future

Webcasts
View
Metabolism, Alcohol & Toxicity

Session 3: Treating patients with NASH and Significant Fibrosis, what the future holds?

Webcasts
View
Metabolism, Alcohol & Toxicity

Discussion

Webcasts
View
Displaying 1 - 9 of 9